Atlas Trials

DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax

Clinical trial NCT02123290 · COMPLETED

Trial details

NCT number
NCT02123290
Sponsor
Medicines for Malaria Venture
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Plasmodium Falciparum MalariaPlasmodium Vivax Malaria
Start date
2016-01-01
Primary completion
2016-01-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.